|
Vaccine Detail
Personalized mature dendritic cell vaccine |
Vaccine Information |
- Vaccine Name: Personalized mature dendritic cell vaccine
- Target Pathogen: Cancer
- Target Disease: Cancer
- Type: whole cell cancer vaccine
- Status: Clinical trial
- Host Species for Licensed Use: None
- Antigen: immunogeneic peptides (NCT02419170)
- Immunization Route: Other
- Description: Immunization against tumor neoantigens may elicit antigen-reactive T cells capable of recognizing and eliminating cancer. This personalized mature dendritic cell vaccine may stimulate the immune system to react to lung cancer cells, in combination with Cyclophosphamide. (NCT02419170)
|
Host Response |
|
References |
NCT02419170: Mature Dendritic Cell Vaccination Against Unique Immunogenic Peptides in Patients With Non Small Cell Lung Cancer (NSCLC) [https://clinicaltrials.gov/study/NCT02419170]
|
|